Buscar
AC Immune SA
ACIUAñadir a la lista de seguimiento
2.660USD
-0.170-6.01%
Cierre 09-24 16:00（ET）
270.71MCap. mercado
PérdidaP/E TTM
Acerca de AC Immune SA Compañía
AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The Company's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. It has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.
Perfil de AC Immune SA
Símbolo de cotizaciónACIU
Nombre de la empresaAC Immune SA
Fecha de salida a bolsaSep 23, 2016
Director ejecutivoPfeifer (Andrea)
Número de empleados133
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 23
DirecciónEPFL Innovation Park
CiudadLAUSANNE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísSwitzerland
Código postal1015
Teléfono41213459121
Sitio Webhttps://www.acimmune.com/
Símbolo de cotizaciónACIU
Fecha de salida a bolsaSep 23, 2016
Director ejecutivoPfeifer (Andrea)
Ejecutivos de AC Immune SA
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Prof. Carl June, M.D.
Prof. Carl June, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
75.27K
+22.01%
Prof. Carl June, M.D.
Prof. Carl June, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
75.27K
+22.01%
Prof. Carl June, M.D.
Prof. Carl June, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
75.27K
+22.01%
Mr. Piergiorgio Donati
Mr. Piergiorgio Donati
Chief Technical Operations Officer
Chief Technical Operations Officer
74.24K
+38.31%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de AC Immune SA?
Los cinco principales accionistas de AC Immune SA son: Prof. Dr. Andrea Pfeifer, Ph.D.
¿Cuántas instituciones poseen acciones de AC Immune SA (ACIU)?
A fecha de 2026Q1, 106 instituciones poseen acciones de AC Immune SA, con un valor de mercado combinado de aproximadamente 26.78M, lo que representa el 26.32% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -1698579.00.